Your browser is no longer supported. Please, upgrade your browser.
Settings
PEN Penumbra, Inc. daily Stock Chart
PEN [NYSE]
Penumbra, Inc.
Index- P/E168.66 EPS (ttm)1.04 Insider Own1.90% Shs Outstand35.04M Perf Week1.16%
Market Cap6.14B Forward P/E127.73 EPS next Y1.37 Insider Trans-13.29% Shs Float32.90M Perf Month-0.96%
Income37.60M PEG8.43 EPS next Q-0.31 Inst Own86.70% Short Float9.18% Perf Quarter-0.77%
Sales556.30M P/S11.04 EPS this Y622.30% Inst Trans-0.67% Short Ratio9.75 Perf Half Y2.16%
Book/sh13.95 P/B12.53 EPS next Y1241.18% ROA6.20% Target Price184.00 Perf Year14.53%
Cash/sh4.79 P/C36.48 EPS next 5Y20.00% ROE8.30% 52W Range121.80 - 194.93 Perf YTD6.37%
Dividend- P/FCF- EPS past 5Y118.50% ROI8.60% 52W High-10.36% Beta0.64
Dividend %- Quick Ratio3.30 Sales past 5Y34.30% Gross Margin67.60% 52W Low43.46% ATR7.92
Employees2700 Current Ratio5.20 Sales Q/Q6.90% Oper. Margin6.60% RSI (14)51.50 Volatility3.62% 4.98%
OptionableYes Debt/Eq0.06 EPS Q/Q-101.70% Profit Margin7.00% Rel Volume0.79 Prev Close176.65
ShortableYes LT Debt/Eq0.05 EarningsMay 07 AMC Payout0.00% Avg Volume309.89K Price174.73
Recom1.30 SMA20-0.25% SMA502.05% SMA2007.40% Volume245,809 Change-1.09%
Mar-05-20Initiated Citigroup Buy $200
Jun-13-19Reiterated BofA/Merrill Buy $150 → $180
May-30-19Upgrade JP Morgan Neutral → Overweight
May-21-19Initiated William Blair Outperform
Oct-29-18Resumed BofA/Merrill Buy $36
Oct-08-18Initiated RBC Capital Mkts Outperform $174
Feb-21-18Initiated William Blair Outperform
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Nov-30-15Reiterated Canaccord Genuity Buy $50 → $58
Oct-13-15Initiated Wells Fargo Outperform
May-29-20 04:05PM  
May-27-20 09:38PM  
04:05PM  
May-15-20 04:05PM  
May-12-20 04:05PM  
May-08-20 03:31AM  
May-06-20 09:07AM  
May-01-20 04:55PM  
Apr-30-20 12:34PM  
Apr-29-20 05:50PM  
04:05PM  
Apr-23-20 04:05PM  
Apr-09-20 05:23AM  
Apr-06-20 04:05PM  
Mar-26-20 01:06PM  
Mar-25-20 02:45PM  
Mar-19-20 09:39AM  
Mar-16-20 12:45PM  
Mar-09-20 09:00AM  
Mar-06-20 09:56AM  
Feb-28-20 12:45PM  
Feb-26-20 09:03AM  
Feb-25-20 06:55PM  
Feb-17-20 05:44PM  
Feb-14-20 05:00AM  
Feb-12-20 10:06AM  
Feb-11-20 04:05PM  
Jan-31-20 09:55AM  
Jan-28-20 09:52AM  
Jan-10-20 06:00PM  
Jan-09-20 08:30AM  
Jan-07-20 02:27PM  
Dec-31-19 04:05PM  
Dec-25-19 04:57AM  
Dec-07-19 06:08PM  
Nov-25-19 04:05PM  
Nov-19-19 04:05PM  
09:18AM  
Nov-14-19 09:11AM  
Nov-11-19 07:34AM  
Nov-07-19 07:35PM  
04:05PM  
Nov-06-19 04:53PM  
09:42AM  
Oct-31-19 10:33AM  
Oct-23-19 08:56AM  
Oct-17-19 04:05PM  
Oct-11-19 11:03AM  
10:13AM  
09:59AM  
Oct-10-19 09:00AM  
Sep-13-19 09:15PM  
Sep-06-19 06:00PM  
Sep-04-19 10:50PM  
Aug-29-19 04:05PM  
Aug-27-19 04:05PM  
08:17AM  
Aug-21-19 10:15PM  
Aug-15-19 01:16AM  
Aug-06-19 10:51PM  
06:45PM  
04:05PM  
Aug-02-19 11:15PM  
Aug-01-19 09:15AM  
Jul-31-19 01:07PM  
Jul-30-19 10:38AM  
Jul-22-19 07:00AM  
Jul-18-19 09:46AM  
Jul-17-19 05:00PM  
09:17AM  
08:51AM  
Jul-16-19 05:00PM  
08:47AM  
08:39AM  
07:59AM  
07:45AM  
Jul-15-19 10:15PM  
09:12AM  
08:33AM  
Jul-12-19 11:49AM  
08:54AM  
06:15AM  
Jul-11-19 01:22PM  
11:10AM  
07:19AM  
Jul-10-19 11:11AM  
08:22AM  
08:10AM  
Jul-09-19 09:38AM  
09:36AM  
09:30AM  
08:18AM  
07:48AM  
Jul-08-19 10:34AM  
10:29AM  
10:25AM  
09:00AM  
Jul-05-19 08:05AM  
07:51AM  
Jul-04-19 09:05AM  
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, Japan, and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; rehabilitation tools that displays and tracks upper-extremity rehabilitation exercises under the REAL Immersive System brand name; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand name, as well as a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and POD Packing Coil brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Elsesser AdamCEO and PresidentMay 11Sale187.678,0001,501,3561,013,582May 13 08:20 PM
Bose AraniChief InnovatorMay 07Sale185.0710,0001,850,700560,662May 11 08:12 PM
Bose AraniChief InnovatorApr 23Sale185.539,1001,688,286570,662Apr 27 08:23 PM
Bose AraniChief InnovatorApr 20Sale185.11900166,599579,762Apr 22 07:47 PM
Kosaraju SridharPresidentApr 15Sale169.282,500423,204155,351Apr 17 09:08 PM
Elsesser AdamChief Executive OfficerApr 13Sale157.818,0001,262,4931,021,582Apr 15 08:48 PM
O'Rourke BridgetDirectorApr 06Sale162.56447,1533,623Apr 08 08:06 PM
Kosaraju SridharPresidentMar 16Sale154.362,500385,901157,851Mar 18 07:55 PM
Elsesser AdamChief Executive OfficerMar 09Sale172.018,0001,376,0961,029,582Mar 11 08:10 PM
Kassing Don W.DirectorFeb 24Sale186.3030456,6351,705Feb 26 08:06 PM
Kosaraju SridharPresidentFeb 18Sale190.702,500476,761160,351Feb 20 08:03 PM
Rothman LynnEVP and Chief Business OfficerFeb 11Option Exercise3.985,00019,90017,332Feb 13 08:41 PM
Rothman LynnEVP and Chief Business OfficerFeb 11Sale185.255,000926,25012,332Feb 13 08:41 PM
Bose AraniChief InnovatorFeb 11Sale185.3010,0001,853,000580,662Feb 13 08:38 PM
Rothman LynnEVP and Chief Business OfficerJan 30Option Exercise3.9810,00039,80022,332Feb 03 08:22 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryJan 30Sale176.253,500616,89254,056Feb 03 08:28 PM
Rothman LynnEVP and Chief Business OfficerJan 30Sale176.0110,0001,760,10812,332Feb 03 08:22 PM
Kosaraju SridharPresidentJan 30Sale176.152,500440,373163,851Feb 03 08:18 PM
O'Rourke BridgetDirectorJan 27Sale172.5016328,1172,911Jan 29 08:10 PM
Sarna SurbhiDirectorJan 27Sale168.7927346,0801,035Jan 29 08:04 PM
Wilder ThomasDirectorJan 02Sale164.1611819,371238Jan 03 08:36 PM
Pray James RobertPresident, InternationalJan 02Sale163.175,335870,517453,431Jan 03 08:32 PM
Grewal HarpreetDirectorJan 02Sale164.1623738,90612,639Jan 03 08:28 PM
Rothman LynnEVP and Chief Business OfficerDec 27Option Exercise3.983201,27412,332Dec 30 08:31 PM
Elsesser AdamChairman and CEODec 11Sale156.648,0001,253,1011,050,982Dec 13 07:57 PM
Pray James RobertPresident, InternationalDec 02Sale174.735,333931,845458,766Dec 04 08:29 PM
Pray James RobertPresident, InternationalNov 18Sale167.535,333893,425464,099Nov 20 08:23 PM
Elsesser AdamChairman and CEONov 11Sale168.708,0001,349,5771,058,982Nov 13 09:03 PM
Rothman LynnEVP and Chief Business OfficerNov 07Sale170.325,000851,602104,807Nov 12 07:54 PM
Rothman LynnEVP and Chief Business OfficerOct 29Sale160.135,000800,650109,807Oct 31 08:31 PM
Pray James RobertPresident, InternationalOct 22Sale150.065,333800,270469,432Oct 24 07:49 PM
Kassing Don W.DirectorOct 14Sale144.091,273183,4321,253Oct 16 08:02 PM
Elsesser AdamChairman and CEOOct 11Sale146.068,0001,168,5001,066,982Oct 15 07:33 PM
Grewal HarpreetDirectorOct 01Sale134.9323731,97812,876Oct 03 08:17 PM
Wilder ThomasDirectorOct 01Sale134.9311815,922356Oct 03 08:14 PM
Pray James RobertPresident, InternationalSep 16Sale150.0065898,700474,765Sep 18 07:51 PM
Rothman LynnEVP and Chief Business OfficerSep 13Sale150.025,000750,100114,807Sep 17 07:19 PM
Pray James RobertPresident, InternationalSep 13Sale150.049,9581,494,098475,423Sep 16 07:30 PM
Pray James RobertPresident, InternationalSep 12Sale150.00507,500485,381Sep 16 07:30 PM
Elsesser AdamChairman and CEOSep 11Sale144.678,0001,157,3401,074,982Sep 13 07:58 PM
Grewal HarpreetDirectorSep 03Sale144.8147568,78513,113Sep 05 08:00 PM
O'Rourke BridgetDirectorSep 03Sale145.8817525,5303,074Sep 05 07:57 PM
Rothman LynnEVP and Chief Business OfficerAug 19Sale144.665,000723,318119,807Aug 21 08:30 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryAug 19Sale144.493,000433,48357,556Aug 21 08:27 PM
Elsesser AdamChairman, CEO and PresidentAug 12Sale149.248,0001,193,9471,082,982Aug 14 07:05 PM
Kosaraju SridharCFO and Head of StrategyAug 01Sale169.365,000846,824166,351Aug 02 08:09 PM
Wilder ThomasDirectorJul 15Sale169.9223740,2713,733Jul 17 07:14 PM
Elsesser AdamChairman, CEO and PresidentJul 11Sale171.848,0001,374,7131,090,982Jul 15 08:23 PM
Kosaraju SridharCFO and Head of StrategyJul 01Sale159.965,000799,802171,351Jul 03 07:30 PM
O'Rourke BridgetDirectorJul 01Sale160.6717528,1173,249Jul 03 07:27 PM
Elsesser AdamChairman, CEO and PresidentJun 11Sale165.088,0001,320,6501,097,982Jun 13 08:26 PM